These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6941659)

  • 1. Treatment of moderate to severe hypertension with labetalol.
    Tötterman KJ; Eisalo A
    Acta Med Scand Suppl; 1981; 646():115-22. PubMed ID: 6941659
    [No Abstract]   [Full Text] [Related]  

  • 2. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A; Raffo M; Sau F; Seguro C; Pirisi R
    Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
    Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
    Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P; Pessina AC; Sperti G; Ventura E; Agnoletto V; Semplicini A; Hlede M; Gava R; Mormino P; Dal Palù C
    G Ital Cardiol; 1983; 13(1):18-22. PubMed ID: 6873535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J; Melot C; Contu E
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid reduction of blood pressure with acute oral labetalol.
    Davies AB; Bala Subramanian V; Gould B; Raftery EB
    Br J Clin Pharmacol; 1982 May; 13(5):705-10. PubMed ID: 7082539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol and 24-hour monitoring of arterial blood pressure in hypertensive patients.
    Ferrari A; Buccino N; Di Rienzo M; Pedotti A; Mancia G; Zanchetti A
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S42-52. PubMed ID: 6169959
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N; Teicher A; Rosenthal T
    Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of hypertension with labetalol.
    Prichard BN; Boakes AJ; Hernández R
    Br J Clin Pharmacol; 1979; 8(Suppl 2):171S-177S. PubMed ID: 526398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.
    Frick MH; Pörsti P
    Br Med J; 1976 May; 1(6017):1046-8. PubMed ID: 773498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol and alprenolol. A comparative investigation of antihypertensive effect.
    Kofod P; Kjaer K; Vejlø S; Hvidt S
    Postgrad Med J; 1980; 56 Suppl 2():69-74. PubMed ID: 7001423
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
    Chalmers AG; Hunter J; Lees CD; Millar JA; Brown JJ; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):183S-187S. PubMed ID: 526399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.